Quorum’s mission is to become the global leader in microbiome therapeutics.

Quorum Innovations

Unlocking the Potential of the Human Microbiome.

Quorum Innovations is a privately-held specialty biopharmaceutical company strategically positioned to become a leader in the emerging field of microbiome therapeutics, and the production of related compounds which enhance and improve pharmaceutical and consumer products.

Quorum Innovations is leading scientific inquiries into the human microbiome and uncovering how vital it is to health. Their scientific team leverages MINE^TM (Microbiome Isolates and Novel Extracts), a proprietary technology platform to isolate and cultivate human microbiome-derived compounds. Discoveries have yielded safe and scalable therapeutics for diseases with unmet needs in underserved medical and consumer markets, as well as innovations to current treatments. Through extensive research, Quorum’s physician-founders, researchers, scientists and staff are focused on discovering, developing and delivering unique and effective biotherapeutics to the marketplace through new ventures and partner relationships.

To learn more, please visit www.quoruminnovations.com